Skip to content

T3 T3ST613Recalls & reported problems

ZimVie US Corp LLC · T3 PRO Non-Platform Switched Implant 6mm (D) X 13mm (L) · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00844868047032), received between Feb 7, 2023 and Feb 16, 2023 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Unspecified Infection2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 16, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT WAS HAVING CHRONIC INFECTIONS, SINCE THE IMPLANT WAS PLACED. THE PATIENT PRESENTED WITH AN INFECTION AND WAS PRESCRIBED ANOTHER SEVEN-DAY COURSE OF ANTIBIOTICS.

    Patient problems: Unspecified Infection

    MAUDE report 16388785 ↗
  • InjuryFeb 7, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    NO ADDITIONAL EVENT INFORMATION RECEIVED AT THE TIME OF THIS REPORT.

    Patient problems: Unspecified Infection

    MAUDE report 16315308 ↗

Other Implant, Endosseous, Root-Form devices

All Implant, Endosseous, Root-Form devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page